SOLV — Neutral (ASignal Rank 3/4)
ASignal's 10+ AI agent pipeline rates SOLV as Neutral with 74% confidence in the Healthcare sector.
AI Analysis Summary
Avoid SOLV due to extreme leverage, overbought technicals, and bearish fundamental outlook.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 35/100
- Bill Ackman (Activist Investing): Grade C — 55/100
- Ray Dalio (Macro/Risk Parity): Grade C — 55/100
Consensus: Bearish
Price Intelligence
- Current price: $68.52
- Price target: $78.56 (+14.7%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: good
- Competitive moat: none
Peer Group Analysis
SOLV is in the “Strong Cash Flow” cluster alongside WSM, WY, WTW, WMT, WELL (127 stocks total). 2 of 127 peers are currently bullish.